Compare Becton Dickinson and Co (BDX) vs BIO-TECHNE Corp (TECH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Becton Dickinson and Co vs BIO-TECHNE Corp — how do they compare? Becton Dickinson and Co trades at $154.29 (market cap $42.39B), while BIO-TECHNE Corp trades at $71.23 (market cap $11.12B). The key difference: Becton Dickinson and Co is far larger — about 3.8× BIO-TECHNE Corp's market cap, and Becton Dickinson and Co pays the higher dividend (2.73%). Which is the better fit depends on your goals.
| BDX | TECH | |
|---|---|---|
Market Cap | $42.39B | $11.12B |
Sector | Health | Health |
52-Week High | $185.39 | $71.38 |
52-Week Low | $135.49 | $43.31 |
Enterprise Value | $58.85B | $11.20B |
Dividend Yield | 2.73% | 0.45% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Becton Dickinson and Co
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.
Read more on BDX →About BIO-TECHNE Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →
